- today
GHRP-6 is known for being a big appetite stimulator, but it is not the strongest GH releasing peptide in the GHRP family. There are other members of the GHRP family we should briefly look at.
This list is in order from strongest to weakest.
1. Hexarelin – The strongest in the family known to give the biggest pulse of all. Will create prolactin and cortisol side effects. Desensitization will happen regardless of the dose.
2. GHRP-2 – Second in the category, however, desensitization is unclear if used beyond saturation dose.
3. GHRP-6 – Third in the lineup for potency, and when shots are broken up, desensitization does not occur. Slightly creates prolactin and cortisol issues.
4. Ipamorelin – This mildest in the bunch, does not create prolactin or cortisol and at very large doses was shown to give a large release of GH without desensitization.
Warning
THE GOODS OFFERED BY THE SELLER IS INTENDED FOR SCIENTIFIC AND DEVELOPMENT PURPOSES ONLY. The goods offered by the Seller include chemical substances that shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals.
References / Links
- Bowers, C. Y., Momany, F., Reynolds, G. A., Chang, D., Hong, A., & Chang, K. (1984). On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114(5), 1537–1545. PubMed
- Ghigo, E., Arvat, E., Gianotti, L., Imbimbo, B. P., Lenaerts, V., Deghenghi, R., & Camanni, F. (1994). Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, in man. Journal of Clinical Endocrinology & Metabolism, 78(4), 693–698. PubMed
- Bowers, C. Y. (1998). Growth hormone-releasing peptide (GHRP). Cellular and Molecular Life Sciences, 54(12), 1316–1329. PubMed
- Ghigo, E., Arvat, E., Gianotti, L., Broglio, F., & Camanni, F. (1997). Growth hormone-releasing peptides. European Journal of Endocrinology, 136(5), 445–460. PubMed
- Jönsson, J. O., Eden, S., Kvist, O., Isaksson, O. G., & Bengtsson, B. A. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552–561. PubMed
Research Quality Begins with Peptide Quality
At Particle Peptides, we believe that reliable research begins with reliable materials. That is why our research peptides are manufactured on cGMP-compliant production lines by a global pharmaceutical CDMO, and every batch undergoes independent third-party testing for:
- Purity
- Identity confirmation
- Peptide content
- Endotoxin levels
- Heavy metals (Class I & II)
- Microbial contamination (TAMC & TYMC)
Transparency and independently verified laboratory data form the foundation of high-quality scientific research.
Disclaimer: All Particle Peptides products are intended exclusively for scientific research and laboratory use. They are not intended for human or veterinary use, nor for the diagnosis, treatment, cure, or prevention of any disease.
